Kyung Ju Ryu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kyung Ju Ryu

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Blood|February 1, 2023

The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphomaSang Eun Yoon, Woorim Kang, Seunghyun Choi, et al.

Digestive Diseases and Sciences|January 22, 2015

Oncogenic Role of BOLL in Colorectal CancerKi Joo Kang, Jeung Hui Pyo, Kyung Ju Ryu, et al.

Blood Advances|December 9, 2025

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphomaSang Eun Yoon, Woorim Kang, Junhun Cho, et al.

Blood|August 9, 2020

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 studySeok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.

Annals of Surgical Oncology|February 8, 2011

Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterationsYoung-Ho Kim, Han Cheol Lee, Seon-Young Kim, et al.

Blood|March 12, 2025

Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell LymphomaSeok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Blood|February 1, 2023

The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphomaSang Eun Yoon, Woorim Kang, Seunghyun Choi, et al.

Digestive Diseases and Sciences|January 22, 2015

Oncogenic Role of BOLL in Colorectal CancerKi Joo Kang, Jeung Hui Pyo, Kyung Ju Ryu, et al.

Blood Advances|December 9, 2025

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphomaSang Eun Yoon, Woorim Kang, Junhun Cho, et al.

Blood|August 9, 2020

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 studySeok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.

Annals of Surgical Oncology|February 8, 2011

Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterationsYoung-Ho Kim, Han Cheol Lee, Seon-Young Kim, et al.

Blood|March 12, 2025

Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell LymphomaSeok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.

Pageof 4